miércoles, 19 de julio de 2023

Lung Cancer Trial of Osimertinib Draws Praise—and Some Criticism

https://www.cancer.gov/news-events/cancer-currents-blog/2023/osimertinib-lung-cancer-adaura?cid=eb_govdel_cancerinfo

No hay comentarios:

Publicar un comentario